We consider an assessment of various insulin control systems through classification by means of different performance characteristics, such as risk of hypoglycemia, hyperglycemia and overall risk. The approach is based on specific, measured patient data under standard insulin therapy. An adaptive prediction technique is used to estimate the differences in blood glucose values produced by control actions that differ from the standard therapy.